These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 22852842

  • 1. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Yang Z, Wu Q, Shi Y, Nie Y, Wu K, Fan D.
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
    [Abstract] [Full Text] [Related]

  • 2. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G, Yu K, Shao L, Yu X, Hu C, Qian P, Xie H, Li J, Zheng J, Zheng S.
    BMC Cancer; 2015 Apr 25; 15():314. PubMed ID: 25927412
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
    Zhong JH, You XM, Gong WF, Ma L, Zhang Y, Mo QG, Wu LC, Xiao J, Li LQ.
    PLoS One; 2012 Apr 25; 7(3):e32159. PubMed ID: 22403631
    [Abstract] [Full Text] [Related]

  • 4. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun S, Jin GJ, Zhao Y, Kang H.
    Asian Pac J Cancer Prev; 2015 Apr 25; 16(7):3009-14. PubMed ID: 25854398
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
    Yuan JM, Fan Y, Ognjanovic S, Wang R, Van Den Berg D, Govindarajan S, Yu MC.
    BMC Gastroenterol; 2013 Feb 18; 13():32. PubMed ID: 23419149
    [Abstract] [Full Text] [Related]

  • 6. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
    Wang Q, Xu L, Wu Q, Zhang M, Zhang J.
    Medicine (Baltimore); 2022 Oct 21; 101(42):e31280. PubMed ID: 36281156
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.
    Eur J Gastroenterol Hepatol; 2012 Apr 21; 24(4):458-63. PubMed ID: 22293333
    [Abstract] [Full Text] [Related]

  • 8. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF, Zheng EQ, Xie M.
    Gene; 2019 Feb 15; 685():143-148. PubMed ID: 30403964
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.
    Wang J, Zhong Y, Meng G.
    Int J Clin Oncol; 2021 Nov 15; 26(11):2053-2064. PubMed ID: 34291370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I, Abu Ella K, El Shaaraway A, Elshayeb E, El-Rebey HS, El Hoseeny M, Naguib M, Nada A.
    Asian Pac J Cancer Prev; 2020 Jul 01; 21(7):2047-2053. PubMed ID: 32711431
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
    Cheng K, Zhao YJ, Liu L, Wan JJ.
    Asian Pac J Cancer Prev; 2013 Jul 01; 14(5):3275-9. PubMed ID: 23803115
    [Abstract] [Full Text] [Related]

  • 16. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T, Wang ZG, Zhang JL, Liu H.
    World J Gastroenterol; 2012 Aug 21; 18(31):4207-14. PubMed ID: 22919255
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.
    JAMA; 2008 Jan 02; 299(1):53-60. PubMed ID: 18167406
    [Abstract] [Full Text] [Related]

  • 18. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
    Zhang LH, Zhang CY, Dai XZ, Zhang J, Zhang F.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct 20; 25(10):749-754. PubMed ID: 29108203
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
    Shen XF, Zeng XT, Jian ZY, Zhou M, Zhou P, Zhang M.
    Oncol Lett; 2015 Nov 20; 10(5):3199-3205. PubMed ID: 26722312
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
    Peng Q, Li S, Lao X, Chen Z, Li R, Qin X.
    Clin Res Hepatol Gastroenterol; 2014 Dec 20; 38(6):735-43. PubMed ID: 25445750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.